Skip to main content
. 2021 Sep 8;40:101122. doi: 10.1016/j.eclinm.2021.101122

Table 2.

Patient Characteristics of CPAP treatment and subgroups. 1n (%); Median (IQR). 2Pearson's Chi-squared test; Wilcoxon rank sum test; Fisher's exact test. Abbreviations used: FiO2, fraction of inspired oxygen; RR, respiratory rate; SpO2, pulse oximetry; CFS, clinical frailty scale.

Variable Overall CPAP group
N = 2331
CPAP Treatment sub-group
p-value [2]
CPAP, clinician discontinued
N =116 [1]
CPAP, patient discontinued
N =117 [1]
Death within 30 days 179 (77%) 83 (72%) 96 (82%) 0.058
Time from inclusion to discharge (of survivors, days) 16 (9, 22) 16 (12, 23) 13 (6, 18) 0.12
Palliative care accessed 111 (49%) 51 (44%) 60 (53%) 0.2
Initial CPAP settings
Pressure (cm H2O) 10 (5, 10) 10 (5, 10) 10 (5, 10) 0.5
FiO2 50 (38, 53) 53 (38, 53) 49 (38, 53) 0.8
Maximum CPAP settings
Pressure 10 (10, 12) 10 (10, 14.2) 10 (10, 12) 0.011
FiO2 53 (46, 56) 53 (48, 56) 53 (46, 60) 0.4
Duration of CPAP use (days) 3 (1, 5) 3 (1, 7) 2 (1, 4) 0.014